Article Details
Retrieved on: 2021-09-08 20:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
(Lyell), (Nasdaq: LYEL), a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors, today announced that members of ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here